Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Cash flows from operating activities:
Net income	$ 67,291	$ 54,862
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property and equipment	4,806	4,690
Amortization of acquired intangibles and other	70,835	71,121
Amortization of debt discount and issuance costs on Notes	2,540	1,621
Stock-based compensation	35,011	30,111
Non-cash lease expense	8,898	6,958
Deferred income taxes	(14,840)	(18,521)
Credit losses and other sales allowances	329	472
Changes in operating assets and liabilities:
Accounts receivable	25,407	31,478
Other assets	15,090	14,294
Inventories	0	2,209
Accounts payable and accrued liabilities	(6,796)	(14,027)
Lease liabilities	(8,682)	(7,860)
Income taxes payable	1,341	2,362
Deferred revenue, net	(9,387)	(39,011)
Net cash flows from operating activities	191,843	140,759
Cash flows used in investing activities:
Purchases of investments	0	(15,262)
Sales and maturities of investments	0	15,700
Purchases of property and equipment	(2,328)	(3,181)
Payments for acquisitions, net of cash acquired	0	(355,250)
Net cash flows used in investing activities	(2,328)	(357,993)
Cash flows (used in) from financing activities:
Proceeds from stock-based compensation plans	17,474	20,373
Payments for taxes related to net share settlements of equity awards	(10,627)	(8,101)
Repurchases of common stock	(86,777)	(30,000)
Proceeds from issuance of senior convertible notes, net of issuance costs of $11,200	438,750	0
Purchase of capped calls	(42,210)	0
Dividend payments to stockholders	(23,814)	(23,669)
Proceeds from the issuance of debt	0	195,000
Repayment of revolving line of credit	(110,000)	(55,000)
Principal payment on term loan	(261,250)	(5,157)
Payment of credit facility debt issuance costs	(6,821)	0
Net cash flows (used in) from financing activities	(85,275)	93,446
Effect of exchange rate changes on cash and cash equivalents	1,515	5,510
Net increase (decrease) in cash and cash equivalents	105,755	(118,278)
Cash and cash equivalents, beginning of period	126,958	256,277
Cash and cash equivalents, end of period	232,713	137,999
Supplemental disclosure:
Cash paid for income taxes, net of refunds of $2,242 in 2024 and $924 in 2023	15,865	14,640
Cash paid for interest	7,961	17,630
Non-cash investing and financing activities:
Total fair value of restricted stock awards, restricted stock units and deferred stock units on date vested	29,036	23,077
Dividends declared and unpaid	$ 8,423	$ 8,354